A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)

被引：10
|
作者：
Goto, Y. [1 ]
Okada, M. [2 ]
Kijima, T. [3 ]
Aoe, K. [4 ]
Kato, T. [5 ]
Fujimoto, N. [6 ]
Nakagawa, K. [7 ]
Takeda, Y. [8 ]
Hida, T. [9 ]
Kanai, K. [10 ]
Imamura, F. [11 ]
Oizumi, S. [12 ]
Takahashi, T. [13 ]
Takenoyama, M. [14 ]
Tanaka, H. [15 ]
Ohe, Y. [16 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Hiroshima Univ, Hiroshima, Japan
[3] Hyogo Coll Med, Nishinomiya, Hyogo, Japan
[4] Natl Hosp Org Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan
[5] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan
[6] Okayama Rosai Hosp, Asbestos Study Ctr, Okayama, Japan
[7] Kinki Univ, Fac Med, Med Oncol, Osaka, Japan
[8] Natl Ctr Global Hlth & Med, Resp Med, Tokyo, Japan
[9] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[10] Wakayama Med Univ, Wakayama, Japan
[11] Osaka Int Canc Inst, Dept Gen Thorac Surg, Osaka, Japan
[12] Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapppro, Japan
[13] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[14] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Fukuoka, Japan
[15] Niigata Canc Ctr Hosp, Internal Med, Niigata, Japan
[16] Natl Canc Ctr, Thorac Oncol, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
malignant pleural mesothelioma; Nivolumab; PD-1;
D O I：
10.1016/j.jtho.2017.09.634
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA 19.01
引用
收藏
页码：S1883 / S1883
页数：1
相关论文
共 50 条
  • [21] Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study
    Mao, Lili
    Fang, Meiyu
    Chen, Yu
    Wei, Xiaoting
    Cao, Jun
    Lin, Jing
    Zhang, Peng
    Chen, Ling
    Cao, Xiao
    Chen, Yujun
    Guo, Jun
    Si, Lu
    CLINICAL CANCER RESEARCH, 2022, 28 (21) : 4642 - 4648
  • [22] Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
    Marty, Francisco M.
    Man, Choy Y.
    van der Horst, Charles
    Francois, Bruno
    Garot, Denis
    Manez, Rafael
    Thamlikitkul, Visanu
    Lorente, Jose A.
    Alvarez-Lerma, Francisco
    Brealey, David
    Zhao, Henry H.
    Weller, Steve
    Yates, Phillip J.
    Peppercorn, Amanda F.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (04): : 542 - 550
  • [23] Multi-arm, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy in malignant pleural mesothelioma (MPM).
    Perez, Jose Manuel Trigo
    Van Brummelen, Emilie
    Levchenko, Evgeny
    Domine, Manuel
    Lopez, Pilar Garrido
    Kindler, Hedy L.
    Morgensztern, Daniel
    Zauderer, Marjorie Glass
    Vansteenkiste, Johan F.
    Ramirez, Santiago Viteri
    Neblett, Katherine Baker
    Botbyl, Jeffrey
    Jose, Eddie
    Zajac, Adina
    Mitrica, Lone
    Sikorski, Robert S.
    Yan, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Phase II Study of Intravenous Doxil® in Malignant Pleural Mesothelioma
    Yun Oh
    Roman Perez-Soler
    Frank V. Fossella
    Bonnie S. Glisson
    Jonathan Kurie
    Garrett L. Walsh
    Mylene Truong
    Dong M. Shin
    Investigational New Drugs, 2000, 18 : 243 - 245
  • [25] A phase II study of gemcitabine in patients with malignant pleural mesothelioma
    van Meerbeeck, JP
    Bass, P
    Debruyne, C
    Groen, HJ
    Manegold, C
    Ardizzoni, A
    Gridelli, C
    van Marck, EA
    Lentz, M
    Giaccone, G
    CANCER, 1999, 85 (12) : 2577 - 2582
  • [26] Phase II study of vinorelbine in patients with malignant pleural mesothelioma
    Ost, E
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (08) : 440 - 441
  • [27] Phase II study of intravenous Doxil® in malignant pleural mesothelioma
    Oh, Y
    Perez-Soler, R
    Fossella, FV
    Glisson, BS
    Kurie, J
    Walsh, GL
    Truong, M
    Shin, DM
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 243 - 245
  • [28] Phase II study of vinorelbine in patients with malignant pleural mesothelioma
    Steele, JPC
    Shamash, J
    Evans, MT
    Gower, NH
    Tischkowitz, MD
    Rudd, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3912 - 3917
  • [29] Cisplatin and gemcitabine in malignant pleural mesothelioma: A phase II study
    Castagneto, B
    Zai, S
    Dongiovanni, D
    Muzio, A
    Bretti, S
    Numico, G
    Botta, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (03): : 223 - 226
  • [30] A PHASE-II STUDY OF PIRARUBICIN IN MALIGNANT PLEURAL MESOTHELIOMA
    KAUKEL, E
    KOSCHEL, G
    GATZEMEYER, U
    SALEWSKI, E
    CANCER, 1990, 66 (04) : 651 - 654
12345